Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 815-122-7 | CAS number: 1446013-08-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 25/01/2019 - 15/03/2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- 2-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(1H-imidazol-5-yl)propanamido]-2-methylpropanoic acid; trifluoroacetic acid
- EC Number:
- 815-122-7
- Cas Number:
- 1446013-08-6
- Molecular formula:
- C27H27F3N4O7
- IUPAC Name:
- 2-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(1H-imidazol-5-yl)propanamido]-2-methylpropanoic acid; trifluoroacetic acid
- Test material form:
- solid: particulate/powder
- Details on test material:
- Target Substance Molecular Formula: C27H27F3N4O7
Target Substance Molecular Weight: 576.51 g/mol
Batch Number: 160004
Physical form and colour: Solid, White powder
Storage: Store at 2÷8°C
Constituent 1
- Specific details on test material used for the study:
- Batch: 160004
Preparation date: 30/11/2016
Expiration date: 09/02/2020
Storage conditions: Refrigerated (2-8 °C)
In vitro test system
- Test system:
- other: SKINETHIC RhE: RECONSTRUCTED HUMAN EPIDERMIS
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Vehicle:
- other: sterile ddH2O
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: SkinEthicTM RHE
- Tissue batch number(s): 19-RHE-032
- Expire: 11/03/2019
- Date of initiation of testing:28/01/2019
Inserts were tested by supplier for the absence of HIV-1 and HIV-2, hepatitis C and B and syphilis. They were certified bacteria and mycoplasma free.
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: room temperature
- Temperature of post-treatment incubation: 37 ± 1°C
At the end of the treatment the meshes were removed and each RHE was washed with 1 ml of D-PBS for 25 times at 5-8 cm of distance from the insert
- Modifications to validated SOP: SOPa-132 rev 1
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1 mg/ml solution
- Incubation time: 3 hours ± 5 min
- Wavelength: 570 ± 8 nm
- Linear OD range of spectrophotometer: the OD linearity range for the measuring device is reported in SOPa 132
QUALITY CONTROL OF THE TEST SYSTEM
- Viability: Acceptance criteria: OD values between 0.8 and 3. Result: 1.2 (CV = 7.5%). PASS.
- Barrier function: Acceptance criteria: 4 hours-10 hours upon treatment with 1% Triton X-100.
Result: 5.3 hours. PASS.
- Morphology: Acceptance criteria: evidence of multi-layered human epidermis-like structure (at least 4 viable cell layers). Result: 5.5 cell layers. PASS.
RHE inserts were employed in the test.
NUMBER OF REPLICATE TISSUES: triplicate
PRE-CHECK:
Pre-check for possible direct MTT reduction with test substance
Being the relative conversion of MTT by the tissue the parameter evaluated in this assay, it was therefore necessary to assess the non-specific reduction of MTT by the substance under test prior to proceed to the skin irritation analysis.
Briefly, in a 24-well plate 4 wells were filled with 0.3 ml of MTT 1 mg/ml in D-PBS without Ca2+/Mg2. Then 16 ± 2 mg of solid test substance or 16 μl of ddH2O as a negative control, were added to two wells each, and carefully mixed. The plate was incubated for 3 hours at 37 ± 1 °C, 5 ± 1 % CO2.
After incubation, the visual scoring of MTT interaction was performed as follows:
Negative control: yellow
- Test substance which did not interact with MTT: yellow
- Test substance that interacted with MTT: blue
The color in both wells treated with the test substance was yellow indicating that no interaction occurred between the substance and MTT.
Pre-check method for colouring test substance
To identify color interference, the test substance was evaluated for intrinsic color or ability to become colored in contact with water/isopropanol, simulating a humid environment.
Briefly, 16 ± 2 mg of solid test substance were added to 300 μl of water in 1 well of a 24 well plate, in duplicate.
The plate was shaken for 60 minutes at 500 rpm at room temperature.
At the end of the shaking period no change in color was observed.
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION:
The test substance was applied topically to RHE inserts, in triplicate for a contact time of 42 minutes at room temperature. Afterwards, test substance was removed from the RHE inserts, using D-PBS without Ca2+/Mg2+. RHE inserts were placed at 37 ± 1°C, 5 ± 1 % CO2 for 42 h. This period allows both for recovery from weak cytotoxic effects and for appearance of clear cytotoxic effects.
DECISION CRITERIA :
- The test substance is considered to be irritant to skin if tissue viability ≤ 50 % after exposure and post-treatment incubation
- The test substance is considered to be non-irritant to skin if tissue viability > 50 % after exposure and post-treatment incubation - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 10 μl of sterile ddH2O and 16 ± 2 mg of solid test substance, were applied to each insert, in triplicate.
NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 16 μl ± 0.5 of Dulbecco's Phosphate Buffered Saline (D-PBS) without Ca2+/Mg2+
POSITIVE CONTROL
- Amount(s) applied (volume or weight): 16 μl ± 0.5
- Concentration (if solution): a 5% Sodium Dodecyl Sulphate solution in sterile ddH2O. - Duration of treatment / exposure:
- 42 minutes at room temperature
- Duration of post-treatment incubation (if applicable):
- 42 h at 37 ± 1°C, 5 ± 1 % CO2
- Number of replicates:
- 3 replicates
Results and discussion
In vitro
Results
- Irritation / corrosion parameter:
- % tissue viability
- Value:
- 94.68
- Vehicle controls validity:
- other: sterile ddH2O
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- - OTHER EFFECTS:
- Visible damage on test system: No
- Direct-MTT reduction: No
- Colour interference with MTT: No
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for blank: yes
- Acceptance criteria met for negative control: yes
- Acceptance criteria met for positive control: yes
- Acceptance criteria met for standard deviation of test substance: yes
Any other information on results incl. tables
Data elaboration for Standard procedure (A):
- Data elaboration was performed using the validated data form (mod 363A GxP).
- Optical density at 570 nm (OD570) was measured for every well of the 96-well plate.
- Mean blank = mean OD calculated from the 3 replicates of blank loaded in wells H1 to H3.
- ODXX570 - Mean Blank where “XX” indicates negative control (NC), positive control (PC) or test substance (TS).
- Mean ODxx570/tissue = mean (ODXX570 - Mean Blank) calculated for the respective tissue.
- Mean ODxx570 = mean (Mean ODxx570/tissue) calculated for each treatment solution (test substances (TS), positive (PC) and negative control (NC)
- Standard deviation = standard deviation of Mean ODxx570 . Note that SD is expressed as % in accordance to acceptance criteria.
- Viability (%) = (mean ODXX570 / mean ODNC570) X 100
- Variation coefficient= SD / Mean ODXX570
In the table below the so calculated data are summarized:
Viability (%) | Variation Coefficient | Result | |
Positive control | 1.60 | 19.33 | IRRITANT |
Test substance | 94.68 | 1.17 | NON IRRITANT |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- According to OECD 439:2015, under the test conditions applied, the test substance is considered NON IRRITANT.
- Executive summary:
The test substance “FMOC-HIS-AIB-OH TFA LS; N-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-L-HISTIDYL-2-METHYLALANINE and TRIFLUOROACETIC ACID (1:1); CAS 1446013-08-6”, batch n° 160004 was subjected to skin irritation assay, conducted according to OECD 439:2015.
The test was carried out using reconstructed human epidermis (RHE), in triplicate. The exposure of the insert to the test substance was carried out for 42 min at room temperature.
After treatment the inserts were rinsed with D-PBS and post-incubated with growth medium for additional 42 hours at 37 ± 1°C, 5 ± 1 % CO2. Finally, inserts were incubated with MTT solution in order to evaluate cell viability which is a direct measure of the irritant potential of the test substance.
Under these conditions, the test substance “FMOC-HIS-AIB-OH TFA LS; N-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-L-HISTIDYL-2-METHYLALANINE and TRIFLUOROACETIC ACID (1:1); CAS 1446013-08-6”, batch n° 160004 resulted NON-IRRITANT.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
